Navigation Links
FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
Date:5/28/2009

SpyGlass(R) Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease

NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SpyScope(R) Access and Delivery Catheter for diagnostic and therapeutic applications during endoscopic procedures in the pancreatico-biliary system. The SpyScope Catheter is used in conjunction with the SpyGlass(R) Direct Visualization System. Previously available for use only in the bile and hepatic ducts, the SpyGlass System can now be used to guide visualization and accessory devices throughout the entire pancreatico-biliary system, enabling physicians to diagnose and treat pancreatic cancer or pre-cancerous tissues.

According to the American Cancer Society, in 2008 nearly 38,000 Americans were diagnosed with cancer of the pancreas -- the fourth-leading cause of cancer death in the U.S. Pancreatic cancer is a "silent" disease, with patients often not exhibiting symptoms until late in the disease process. As a result, the majority of patients with late-stage disease have a poor prognosis for survival.

"Early detection is critical to improving outcomes in patients with pancreatic cancer, but the 'silent' nature of the disease -- coupled with the inadequate diagnostic options of traditional x-ray or surgery -- have historically made this very difficult," said Douglas Pleskow, M.D., Beth Israel Deaconess Medical Center, Boston. "The SpyGlass System represents a tremendous advance in both the diagnosis and treatment process of pancreatic disease. With SpyGlass, I can navigate the ducts seamlessly, visualize the areas of interest and deliver treatment. In addition, I can use complementary
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
2. FDA Clears New Applicators for Endometrial Cancer Treatment With Xofts Axxent(R) Electronic Brachytherapy System
3. FDA Clears First Medical Product Made From Yulex(R) Natural Rubber
4. Device That Clears Debris From Artery Aids Blood Flow in PCI
5. FDA Clears Expanded Use of Xofts Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications
6. New filter clears up fiber optic communications
7. FDA Clears Biospace meds Revolutionary Low Dose Xray Imager
8. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
9. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
10. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
11. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Fertility Associates of Memphis has announced a new ... network of more than 20 contributing fertility practices ... access to a national pool of frozen donor ... of Memphis is the only fertility clinic in the ... Dr. William Kutteh , director of Fertility Associates of ...
(Date:12/19/2014)... -- Naurex Inc., a biopharmaceutical company leveraging its unique ... central nervous system, today announced that Norbert Riedel ... at the 33 rd annual J.P. Morgan Healthcare ... p.m. PST on Tuesday, January 13, 2015, at the ... About Naurex Inc. ...
(Date:12/19/2014)... DUBLIN , Dec. 19, 2014 Research ... announced the addition of the "Technology Innovations ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... Innovations in Smart Fabrics" offers a detailed assessment ... Key Findings: 1. ...
(Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for ... Excellence in the Neurosciences (CEN), and professor of pharmacology ... as a member of the prestigious Dana Alliance for ... Maine to receive this honor. , The Dana ... the Dana Foundation. Its mission is to advance ...
Breaking Biology Technology:Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Technology Innovations in Smart Fabrics (Technical Insights) 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3
... Leaf Venture Partners Commit To Purchase ... to $300 Million ... Debt, VANCOUVER, July 7 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. ... pharmaceutical and,medical device company, today announced that Angiotech,s Board ...
... ,Shire Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty,biopharmaceutical company, ... 2008, Results press release will be issued ... Investor meeting and conference call time: 14:30 ... and conference call:, Angus Russell, Chief Executive Officer, ...
... N.J., July 3 On June 27, 2008,GeneraMedix ... Drug,Administration (FDA) for its Epoprostenol for Injection 1.5 ... 1.5 mg is indicated for the long-term,intravenous treatment ... the scleroderma spectrum of disease in NYHA,Class III ...
Cached Biology Technology:Angiotech to Establish Separate Operating and Royalty Businesses 2Angiotech to Establish Separate Operating and Royalty Businesses 3Angiotech to Establish Separate Operating and Royalty Businesses 4Angiotech to Establish Separate Operating and Royalty Businesses 5Angiotech to Establish Separate Operating and Royalty Businesses 6Angiotech to Establish Separate Operating and Royalty Businesses 7Angiotech to Establish Separate Operating and Royalty Businesses 8Angiotech to Establish Separate Operating and Royalty Businesses 9Angiotech to Establish Separate Operating and Royalty Businesses 10Angiotech to Establish Separate Operating and Royalty Businesses 11Angiotech to Establish Separate Operating and Royalty Businesses 12Angiotech to Establish Separate Operating and Royalty Businesses 13Angiotech to Establish Separate Operating and Royalty Businesses 14Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008 2GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2
(Date:12/10/2014)... Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ... the ultimate driver in long-term mass consumer adoption of ...
(Date:12/10/2014)... , December 9, 2014 ... ITN,s BCARD Platform   ... enterprise meeting scheduling solutions for business-to-business (B2B) events, ... world leader in mobile near-field communication (NFC), Bluetooth ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow ...
(Date:12/3/2014)... 2014   Marvin Test Solutions , a ... for military, aerospace, and manufacturing organizations, today announced ... TS-900 PXI semiconductor test platform . The ... systems to customers at a fraction of the ... ATE. "Our semiconductor customers asked ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... first-of-its-kind antidepressant drug discovered by a Northwestern University professor ... antidepressant therapies has been shown to alleviate symptoms within ... last for about seven days from a single dose. ... for learning and memory -- a very different approach ...
... known how bacteria exposed to antibiotics for long periods will ... of their cells, for instance, or modifying the compounds so ... another possible mechanism of antibiotic "resistance" in soil. In a ... of Environmental Quality , a group of Canadian and ...
... 6 de dezembro de  2012 A Integrated ... com a certificação pelo FBI de sua novíssima ... da IB criou o novo produto usando a ... junto com um transistor de película fina (TFT). ...
Cached Biology News:New antidepressant acts very rapidly and is long lasting 2New antidepressant acts very rapidly and is long lasting 3Antibiotic-eating bug unearthed in soil 2Antibiotic-eating bug unearthed in soil 3Integrated Biometrics Apresenta Sherlock, o Menor, Mais Leve e Fino Sensor Appendix F Mobile ID 2
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody...
B3GALT2 Immunogen: B3GALT2 (NP_003774, 324 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... polyclonal to ThPok ( Abpromise for all ... peptide conjugated to KLH derived from within residues ... (Note: the amino acid sequence is proprietary) ... Entrez Gene ID: 51043 ...
Rabbit polyclonal to SUR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide Entrez Gene ID: 6833 Swiss Protein ID: Q09428...
Biology Products: